Skip to main content
Clinical Trials/CTRI/2022/01/039671
CTRI/2022/01/039671Not yet recruitingPhase 3

â??A NON-RANDOMIZED SINGLE BLIND CLINICAL STUDY TO ASSESS THE EFFICACY OF BACH FLOWER REMEDIES IN MANAGEMENT OF GENERALISED ANXIETY DISORDER IN AGE GROUP OF ABOVE 18 YEARS.â??

Dr G V GAYATRI0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1)All the persons fulfilling the case definition given by ICD-10; DSM-5 criteria.
  • 2)Persons having GAD-7 Score would be greater then or equal to 10.
  • 3)Persons who are willing to take treatment regularly and co-operate for regular follow-ups.
  • 4)Persons belonging to above 18 years age group.

Exclusion Criteria

  • 1)Persons requiring IPD management.
  • 2)BELOW 18 YEARS OF AGE.
  • 3)Persons having GAD-7 Score would be lesser than 10.
  • 4)Severely ill or emergency cases.
  • 5)Persons presenting with gross pathological cases.
  • 6)Persons suffering any systemic disorder which interfere with present study will be excluded.
  • 7)Pregnant women and related disorders.

Investigators

Sponsor
Dr G V GAYATRI

Similar Trials